Neil Shah MD, Presenter: Nothing to Disclose

Juan Camilo Camacho, Abstract Co-Author: Nothing to Disclose

Courtney Ann Coursey Moreno MD, Abstract Co-Author: Nothing to Disclose

Pardeep Kumar Mittal MD, Abstract Co-Author: Nothing to Disclose

To explain the difference between extracelluar and hepatobiliary contrast To demonstrate the role of different contrast agents in imaging bile duct injuries pre and post operatively To provide examples of challenging cases, including hepatocellular carcinoma, focal nodular hyperplasia, adenoma, and hemangioma

Hepatobiliary contrast agents are one of several types of contrast agents available for hepatic MRI. They can be used to detect and characterize focal lesions (especially challenging cases), evaluate diffuse hepatocellular disease, and evaluate biliary tree anatomy and function. Contrast Agents Mechanism of Action ---extracellular ---hepatobiliary Role of Different Contrast Agents in Bile Duct Injuries MRI with Hepatobiliary Contrast: Bile Duct Injuries ---bile duct leak ---stricture ---occlusion ---transection ---biloma MRI with Hepatobiliary Contrast: Other Challenging Cases ---hepatocellular carcinoma ---focal nodular hyperplasia ---adenoma ---hemangioma  Summary: Hepatobiliary contrast agents play a key role in accurately recognizing and classifying bile duct injuries. Additionally, hepatobiliary contrast assists in evaluating challenging hepatic MRI cases.

http://abstract.rsna.org/uploads/2014/14001544/14001544_n3yj.pdf

Shah, N, Camacho, J, Coursey Moreno, C, Mittal, P, Role of Hepatobiliary Contrast Agents in MRI Evaluation of Challenging Cases, including Bile Duct Injuries.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14001544.html